Less intense radiation for early HPV throat cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study tries to see if less intense radiation can still work well for certain throat cancers linked to HPV. It is looking for people with early stage HPV-positive oropharynx cancer who may benefit from a lighter treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have p16 positive or HPV positive oropharynx cancer (like throat or tonsil cancer).
- Your cancer is stage I or II (small tumor, with or without small lymph nodes).
- You have never smoked, or you quit more than 6 months ago and smoked less than 15 pack-years total.
- You can do normal daily activities with at least a little help (Karnofsky score of 60 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving less radiation (while using standard chemotherapy) can treat HPV-related throat cancer effectively. It may help reduce radiation exposure while still controlling the cancer.
This trial tests whether giving less radiation after surgery is safe and effective for people with early-stage HPV-related throat cancer. It aims to reduce side effects while still controlling the cancer.
This trial tests a less intense treatment plan for HPV-positive throat cancer that is caught early or moderately advanced. The goal is to keep the cancer from coming back while reducing side effects from standard therapy.
This study tests a way to use less radiation for HPV-related throat cancer. Doctors will adjust your treatment based on a simple blood test that tracks cancer DNA, so you may get only the treatment you need.
This trial tests whether a lower dose of radiation to the neck is safe and effective for people with HPV-related oropharyngeal cancer. It may reduce side effects while still treating the cancer.
This trial tests whether using a de-escalated (lower/intensity-reduced) radiation approach can treat HPV-positive oropharyngeal squamous cell carcinoma. It may help reduce side effects while still keeping the cancer under control.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.